Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does XYLOMETAZOLINE Cause Pulmonary embolism? 108 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Pulmonary embolism have been filed in association with XYLOMETAZOLINE (Metarivin Soln. 0.1%). This represents 20.0% of all adverse event reports for XYLOMETAZOLINE.

108
Reports of Pulmonary embolism with XYLOMETAZOLINE
20.0%
of all XYLOMETAZOLINE reports
107
Deaths
102
Hospitalizations

How Dangerous Is Pulmonary embolism From XYLOMETAZOLINE?

Of the 108 reports, 107 (99.1%) resulted in death, 102 (94.4%) required hospitalization, and 95 (88.0%) were considered life-threatening.

Is Pulmonary embolism Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for XYLOMETAZOLINE. However, 108 reports have been filed with the FAERS database.

What Other Side Effects Does XYLOMETAZOLINE Cause?

Off label use (161) Abdominal distension (155) Nausea (155) Hyponatraemia (154) Stress (152) Multiple organ dysfunction syndrome (151) Abdominal pain (149) General physical health deterioration (148) Appendicitis (147) Vomiting (147)

What Other Drugs Cause Pulmonary embolism?

RIVAROXABAN (3,282) LENALIDOMIDE (2,976) APIXABAN (2,714) ETHINYL ESTRADIOL\ETONOGESTREL (2,370) TESTOSTERONE (2,043) RITUXIMAB (1,764) ADALIMUMAB (1,663) PREDNISONE (1,586) METHOTREXATE (1,508) DEXAMETHASONE (1,336)

Which XYLOMETAZOLINE Alternatives Have Lower Pulmonary embolism Risk?

XYLOMETAZOLINE vs XYREM XYLOMETAZOLINE vs XYREM , /ML XYLOMETAZOLINE vs YASMIN XYLOMETAZOLINE vs YAZ XYLOMETAZOLINE vs YTTRIUM Y-90

Related Pages

XYLOMETAZOLINE Full Profile All Pulmonary embolism Reports All Drugs Causing Pulmonary embolism XYLOMETAZOLINE Demographics